Praxis Precision Medicines Ownership | Who Owns Praxis Precision Medicines?


OverviewForecastRevenueFinancialsChartTranscripts

Praxis Precision Medicines Ownership Summary


Praxis Precision Medicines is owned by 112.45% institutional investors, 0.16% insiders. Adage capital partners gp is the largest institutional shareholder, holding 9.19% of PRAX shares. American Funds SMALLCAP World A is the top mutual fund, with 3.71% of its assets in Praxis Precision Medicines shares.

PRAX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockPraxis Precision Medicines112.45%0.16%-12.60%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Adage capital partners gp1.97M9.19%$83.03M
Cormorant asset management, lp1.63M7.57%$68.33M
Blackrock funding, inc. /de1.59M7.40%$66.86M
Price t rowe associates inc /md/1.21M6.40%$93.01M
Vanguard group1.06M5.63%$81.86M
Janus henderson group929.52K4.92%$71.62M
Soleus capital management966.74K4.50%$40.65M
Point72 asset management954.08K4.44%$40.12M
Perceptive advisors752.92K3.51%$31.66M
Baker bros. advisors lp689.49K3.21%$28.99M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Velan capital investment management lp185.00K7.21%$7.01M
72 investment65.93K7.02%$2.50M
Cormorant asset management, lp1.63M5.09%$68.33M
Acuta capital partners74.09K4.35%$3.12M
5am venture management170.00K3.12%$13.08M
Ally bridge group (ny)80.88K2.83%$3.40M
Soleus capital management966.74K2.69%$40.65M
Ikarian capital276.95K2.24%$11.65M
Perceptive advisors752.92K1.17%$31.66M
Sphera funds management109.76K1.08%$4.62M

Top Buyers

HolderShares% AssetsChange
Point72 asset management954.08K0.08%620.54K
Janus henderson group929.52K0.04%405.96K
Baker bros. advisors lp689.49K0.28%357.95K
Adage capital partners gp1.97M0.14%231.83K
Logos global management lp225.00K1.05%225.00K

Top Sellers

HolderShares% AssetsChange
Vr adviser---989.99K
Capital research global investors---853.75K
Ra capital management---761.96K
Kingdon capital management---303.00K
Perceptive advisors752.92K1.17%-227.97K

New Positions

HolderShares% AssetsChangeValue
Logos global management lp225.00K1.05%225.00K$9.46M
Vivo capital167.60K0.72%167.60K$7.05M
Norges bank118.90K0.00%118.90K$9.15M
Prelude capital management19.90K0.08%19.90K$836.79K
Woodline partners lp9.95K0.01%9.95K$765.60K

Sold Out

HolderChange
Ifp advisors-1.00
Parallel advisors-2.00
Creative financial designs inc /adv-6.00
Principal securities-6.00
Assetmark-7.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025155-6.06%24,147,5133.31%1120.91%884.76%33-35.29%
Mar 31, 202516-90.86%7,276,078-66.50%340.26%10-89.47%3-94.12%
Dec 31, 202473-50.00%6,922,762-63.30%360.37%44-41.33%21-54.35%
Sep 30, 202414617.74%18,864,9992.39%991.04%75-8.54%4670.37%
Jun 30, 20241245.98%18,424,83215.78%970.75%82-5.75%2750.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds SMALLCAP World A748.24K3.71%-139.82K
Vanguard Total Stock Mkt Idx Inv673.37K3.20%-14.92K
Vanguard US Total Market Shares ETF541.27K2.68%-
iShares Russell 2000 ETF421.02K2.00%-7.98K
Janus Henderson Global Life Sciences402.45K1.98%223.64K
T. Rowe Price New Horizons393.45K1.93%-1.96K
US Small-Cap Growth II Equity Comp393.45K1.93%4.67K
Janus Henderson Global Life Sciences D402.45K1.91%43.33K
Renaissance Global Health Care388.36K1.85%-
T. Rowe Price Health Sciences374.76K1.84%-14.11K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 14, 2024Nemiroff Alex General Counsel and SecretarySell$660.83K
Nov 14, 2024Mastrocola Lauren Principal Accounting OfficerSell$424.32K
Oct 05, 2023DeSimone Jill-Buy$25.38K
Jun 27, 2023Souza Marcio Chief Executive OfficerBuy$10.59K
Mar 24, 2023Kelly Timothy Edwin Chief Financial OfficerBuy$7.00K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q4-2
2024 Q3--

PRAX Ownership FAQ


Who Owns Praxis Precision Medicines?

Praxis Precision Medicines shareholders are primarily institutional investors at 112.45%, followed by 0.16% insiders and -12.61% retail investors. The average institutional ownership in Praxis Precision Medicines's industry, Biotech Stocks , is 306.59%, which Praxis Precision Medicines falls below.

Who owns the most shares of Praxis Precision Medicines?

Praxis Precision Medicines’s largest shareholders are Adage capital partners gp (1.97M shares, 9.19%), Cormorant asset management, lp (1.62M shares, 7.57%), and Blackrock funding, inc. /de (1.59M shares, 7.40%). Together, they hold 24.17% of Praxis Precision Medicines’s total shares outstanding.

Does Blackrock own Praxis Precision Medicines?

BlackRock is not among the top 10 institutional shareholders of Praxis Precision Medicines.

Who is Praxis Precision Medicines’s biggest shareholder by percentage of total assets invested?

Velan capital investment management lp is Praxis Precision Medicines’s biggest shareholder by percentage of total assets invested, with 7.21% of its assets in 185K Praxis Precision Medicines shares, valued at 7.01M$.

Who is the top mutual fund holder of Praxis Precision Medicines shares?

American Funds SMALLCAP World A is the top mutual fund holder of Praxis Precision Medicines shares, with 3.71% of its total shares outstanding invested in 748.24K Praxis Precision Medicines shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools